KC

Kanamanuri Chandra Sekhar

Active Director Director DIN 10532159
DIN 10532159 First appointment Mar 2024 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanamanuri Chandra Sekhar

Data last updated:

Kanamanuri Chandra Sekhar is a Director at Kjredy Biosciences Private Limited (since 2024). The company operates in Professional Services.

DIN 10532159
Primary Designation Director
Industry Professional Services
First Appointment 02 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kjredy Biosciences Private Limited U72100AP2024PTC114079
Director02 Mar 20242024Active

Board colleagues of Kanamanuri Chandra Sekhar

Directorship timeline

Open interactive timeline →
Kjredy Biosciences Private Limited
Premium access

Shareholding and investment profile for Kanamanuri Chandra Sekhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanamanuri Chandra Sekhar

Kanamanuri Chandra Sekhar currently holds 1 directorship: Kjredy Biosciences Private Limited (Director, since 02 Mar 2024).

Kanamanuri Chandra Sekhar was first appointed on 02 Mar 2024 as Director at Kjredy Biosciences Private Limited.

The current boards of Kanamanuri Chandra Sekhar's companies include Kanala Jagadeeswara Reddy (Kjredy Biosciences Private Limited), Siddagalla Nagachandrudu (Kjredy Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available